医学
无容量
内科学
吉西他滨
临床终点
肿瘤科
鼻咽癌
胃肠病学
癌症
放射治疗
临床试验
免疫疗法
作者
Hyun Ae Jung,Keon Uk Park,Sang‐Hee Cho,Jinyeong Lim,Keun‐Wook Lee,Min Hee Hong,Tak Yun,Ho Jung An,Woong‐Yang Park,Sérgio Pereira,Chan‐Young Ock,Bhumsuk Keam
标识
DOI:10.1158/1078-0432.ccr-22-1238
摘要
Nivolumab plus gemcitabine showed promising efficacy with favorable toxicity profiles in patients with advanced NPC in whom platinum-based combination chemotherapy failed.
科研通智能强力驱动
Strongly Powered by AbleSci AI